# Zinc Supplementation: Evidence-Based Guide
Canonical: https://www.migaku.app/guides/zinc-guide
Category: ai-evidence-guide
Summary: Zinc supplementation shows potential benefits in liver cirrhosis and immune function in the elderly, with evidence indicating improvements in biochemical outc
Last reviewed: 2026-06-26
Reviewed by: Migaku AI Evidence Review
## Quick Answer
Zinc supplementation shows potential benefits in liver cirrhosis and immune function in the elderly, with evidence indicating improvements in biochemical outcomes and interferon-γ production.

## Key Takeaways
- A meta-analysis of zinc supplementation in liver cirrhosis patients demonstrated significant improvements in biochemical markers, though specific metrics were not detailed [Source 1].
- In a study with elderly participants (n=50), zinc aspartate supplementation over 7 days increased serum zinc levels and IFN-γ production, with statistical significance in those using proton pump inhibitors (p<0.05) [Source 2].
- The same study noted a trend towards increased ZIP8 expression, though no direct correlation with zinc status was established [Source 2].
- Zinc's role in modulating protein expression and cytokine production is supported by molecular evidence, suggesting broader implications for immune health [Source 2].

## Clinical Evidence Deep-Dive
Gong Y's meta-analysis evaluated the impact of zinc supplementation on liver cirrhosis, a condition characterized by significant biochemical disruptions. The systematic review, classified as level 1 evidence, aggregated data from multiple trials to assess clinical outcomes. While specific p-values were not disclosed, the overall findings suggest a positive effect of zinc on liver function markers [Source 1].

Olah K's research article focused on zinc's impact on immune function in the elderly, a population with compromised immunity. The study involved 50 participants, with a subset using proton pump inhibitors. Zinc aspartate was administered for approximately 7 days, resulting in increased serum zinc levels and IFN-γ production. The statistical significance of these findings in PPI users (p<0.05) highlights the potential for zinc to enhance immune responses in specific subpopulations. However, the study's small sample size and short duration limit the generalizability of these results [Source 2].

The research also explored the molecular mechanisms of zinc, particularly its role in ZIP8 expression and cytokine modulation. Although a direct correlation between zinc status and ZIP8 expression was not established, the observed trends suggest further investigation is warranted. These findings underscore zinc's potential in addressing age-related immune decline [Source 2].

## Practical Protocol
Clinical reference - consult a physician: Zinc aspartate supplementation at dosages used in the study (exact dosage not specified) for approximately 7 days may benefit elderly individuals, particularly those on proton pump inhibitors. Dosage adjustments should be made based on individual health status and under medical supervision.

## FAQ
**Can zinc supplementation improve liver function in cirrhosis patients?**
Meta-analysis data indicate improvements in biochemical markers, suggesting potential benefits for liver function [Source 1].

**Does zinc supplementation affect immune function in the elderly?**
Yes, zinc aspartate increased serum zinc levels and IFN-γ production in elderly participants, especially those on PPIs [Source 2].

**Is there a correlation between zinc status and ZIP8 expression?**
The study found no clear correlation, though trends suggest further research is needed [Source 2].

## References
[1] Zinc supplementation in liver cirrhosis: meta-analysis of its effect on biochemical and clinical outcomes. Gong Y. 2026. https://pmc.ncbi.nlm.nih.gov/articles/PMC12825225/

[2] Zinc Supplementation Partially Reconstitutes Impaired Interferon-γ Production in the Elderly. Olah K. 2026. https://pmc.ncbi.nlm.nih.gov/articles/PMC12842025/